Matches in SemOpenAlex for { <https://semopenalex.org/work/W2360465279> ?p ?o ?g. }
Showing items 1 to 87 of
87
with 100 items per page.
- W2360465279 endingPage "9" @default.
- W2360465279 startingPage "866" @default.
- W2360465279 abstract "Lacking enough knowledge of pediatric cancer pain and pediatric dosage form of analgesics, current treatment of pediatric cancer pain in China is unsatisfactory. This study was to probe the efficacy and safety of treating pediatric cancer pain with analgesics for adults through summarizing the experience of diagnosis and treatment in Cancer Center of Sun Yet-sen University.Basing on the components and the endurable dosage of each component for children, we formulated the appropriate dosage and usage of a few analgesics (including sustained release tablets of morphine, oxycodone and transdermal fantanyl) available in China, most of which were used in adults. Cancer pain of 139 children with newly diagnosed tumors were treated according to the World Health Organization (WHO) analgesic ladder, including 19 cases of mild pain, 41 cases of moderate pain and 79 cases of severe pain. Efficacy and adverse events were evaluated.Of the 139 patients, 104 (74.8%) were treated with analgesics of 1 WHO ladder step, 35 (25.2%) were treated with increased WHO ladder steps (ladder 1-->2 or 2-->3) or reduced WHO ladder steps (ladder 3-->2 or 2-->1). The total response rate for pain relief was 100%: 129 (92.8%) patients had complete relief, 7 (5.0%) had obvious relief, 3(2.2%) had moderate relief. The median time for pain control was 5 days (range, 1-12 days). Sustained release tablets of morphine, transdermal fantanyl, and sustained release tablets of oxycodone were used in 20, 28, and 40 patients, respectively. The median ages of the 3 groups were 10 (5-18), 6 (2.3-16), and 5 (2.5-16) years, respectively. The median of maximum dosages of the 3 single drugs were 20 (10-70) mg, 25 (12.5-50) microg/h, and 10 (5-30) mg, respectively. The median doses used in the 3 groups were 100 (20-360) mg, 5 (1.25-7.5) mg, and 60 (10-200) mg, respectively. The non-steroid anti-inflammatory drug-induced adverse events were nausea and vomiting with very low frequencies. The weak opioid and strong opioid drug-induced adverse events included constipation, nausea, vomiting, and somnolence, all of which were reversible. No severe adverse events, including respiratory depression and drug addiction, happened.The WHO ladder approach for cancer pain is appropriate for children. Currently in China, most analgesics for adults could be used for pediatric cancer pain treatment." @default.
- W2360465279 created "2016-06-24" @default.
- W2360465279 creator A5005791381 @default.
- W2360465279 creator A5016619271 @default.
- W2360465279 creator A5021914782 @default.
- W2360465279 creator A5025750002 @default.
- W2360465279 creator A5060559576 @default.
- W2360465279 creator A5090111080 @default.
- W2360465279 creator A5090460203 @default.
- W2360465279 date "2007-08-01" @default.
- W2360465279 modified "2023-09-26" @default.
- W2360465279 title "[Feasibility to treat pediatric cancer pain with analgesics for adults and their efficacy]." @default.
- W2360465279 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17697549" @default.
- W2360465279 hasPublicationYear "2007" @default.
- W2360465279 type Work @default.
- W2360465279 sameAs 2360465279 @default.
- W2360465279 citedByCount "1" @default.
- W2360465279 countsByYear W23604652792015 @default.
- W2360465279 crossrefType "journal-article" @default.
- W2360465279 hasAuthorship W2360465279A5005791381 @default.
- W2360465279 hasAuthorship W2360465279A5016619271 @default.
- W2360465279 hasAuthorship W2360465279A5021914782 @default.
- W2360465279 hasAuthorship W2360465279A5025750002 @default.
- W2360465279 hasAuthorship W2360465279A5060559576 @default.
- W2360465279 hasAuthorship W2360465279A5090111080 @default.
- W2360465279 hasAuthorship W2360465279A5090460203 @default.
- W2360465279 hasConcept C121608353 @default.
- W2360465279 hasConcept C126322002 @default.
- W2360465279 hasConcept C170493617 @default.
- W2360465279 hasConcept C197934379 @default.
- W2360465279 hasConcept C205679159 @default.
- W2360465279 hasConcept C2776029756 @default.
- W2360465279 hasConcept C2777389121 @default.
- W2360465279 hasConcept C2778904085 @default.
- W2360465279 hasConcept C2780820201 @default.
- W2360465279 hasConcept C2781063702 @default.
- W2360465279 hasConcept C2993247534 @default.
- W2360465279 hasConcept C2993561819 @default.
- W2360465279 hasConcept C42219234 @default.
- W2360465279 hasConcept C71924100 @default.
- W2360465279 hasConcept C98274493 @default.
- W2360465279 hasConceptScore W2360465279C121608353 @default.
- W2360465279 hasConceptScore W2360465279C126322002 @default.
- W2360465279 hasConceptScore W2360465279C170493617 @default.
- W2360465279 hasConceptScore W2360465279C197934379 @default.
- W2360465279 hasConceptScore W2360465279C205679159 @default.
- W2360465279 hasConceptScore W2360465279C2776029756 @default.
- W2360465279 hasConceptScore W2360465279C2777389121 @default.
- W2360465279 hasConceptScore W2360465279C2778904085 @default.
- W2360465279 hasConceptScore W2360465279C2780820201 @default.
- W2360465279 hasConceptScore W2360465279C2781063702 @default.
- W2360465279 hasConceptScore W2360465279C2993247534 @default.
- W2360465279 hasConceptScore W2360465279C2993561819 @default.
- W2360465279 hasConceptScore W2360465279C42219234 @default.
- W2360465279 hasConceptScore W2360465279C71924100 @default.
- W2360465279 hasConceptScore W2360465279C98274493 @default.
- W2360465279 hasIssue "8" @default.
- W2360465279 hasLocation W23604652791 @default.
- W2360465279 hasOpenAccess W2360465279 @default.
- W2360465279 hasPrimaryLocation W23604652791 @default.
- W2360465279 hasRelatedWork W1000337687 @default.
- W2360465279 hasRelatedWork W1495096574 @default.
- W2360465279 hasRelatedWork W1842104152 @default.
- W2360465279 hasRelatedWork W1976520695 @default.
- W2360465279 hasRelatedWork W2061355160 @default.
- W2360465279 hasRelatedWork W2082042096 @default.
- W2360465279 hasRelatedWork W2147272783 @default.
- W2360465279 hasRelatedWork W2358657645 @default.
- W2360465279 hasRelatedWork W2359309530 @default.
- W2360465279 hasRelatedWork W2362740208 @default.
- W2360465279 hasRelatedWork W2373488073 @default.
- W2360465279 hasRelatedWork W2382427873 @default.
- W2360465279 hasRelatedWork W2382634824 @default.
- W2360465279 hasRelatedWork W2389914485 @default.
- W2360465279 hasRelatedWork W2390042449 @default.
- W2360465279 hasRelatedWork W2890220930 @default.
- W2360465279 hasRelatedWork W3028751563 @default.
- W2360465279 hasRelatedWork W3031413927 @default.
- W2360465279 hasRelatedWork W3031674835 @default.
- W2360465279 hasRelatedWork W3208027969 @default.
- W2360465279 hasVolume "26" @default.
- W2360465279 isParatext "false" @default.
- W2360465279 isRetracted "false" @default.
- W2360465279 magId "2360465279" @default.
- W2360465279 workType "article" @default.